Robot-assisted laparoscopic prostatectomy performed in a patient with severe thrombocytopenia due to primary myelofibrosis

Robot-assisted laparoscopic prostatectomy (RALP) has emerged as a minimally invasive alternative to open radical prostatectomy (ORP) for the treatment of clinically localized prostate cancer. In comparison to the open procedure, there is significantly less intraoperative blood loss during RALP. This benefit has allowed RALP to become a feasible option for patients who would be poor candidates for ORP, including those patients with intrinsic hematological disorders. In this case study, we report a successfully performed RALP in a patient with severe thrombocytopenia in the presence of primary myelofibrosis.